Diabetes is an important public health problem in the world, and the situation in China is particularly serious. The prevalence rate is as high as 11.2%, and the number of patients with diabetes ranks first in the world; Moreover, the current management situation is not optimistic, with many problems such as low awareness rate, low diagnosis rate, low treatment rate, and low control rate. In order to better promote the prevention and treatment of diabetes and improve the awareness and management ability of doctors and patients on diabetes. From October 2023 to March 2024, the "Ruize Huaxia" diabetes Comprehensive Management Compliance Improvement Project, sponsored by Chengdu High tech Medical Association and undertaken by the Western Endocrine Metabolism Branch of Chengdu High tech Medical Association, was held during this period. The activities were invited to Tongnanwei, Professor of West China Hospital of Sichuan University, Yang Gangyi, Professor of the Second Affiliated Hospital of Chongqing Medical University, and Li Shengbing, Professor of the Second Affiliated Hospital of Chongqing Medical University Professor Wei Dong and other industry experts from Chengdu Second People's Hospital held academic conferences, science popularization campaigns, and industry exchanges around relevant knowledge content. Representatives participating in the project expressed great benefits and hoped to participate in similar conferences in the future.